Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darrick Carter

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Scientific Reports|May 13, 2022
Translational development of a tumor junction opening technologyJiho Kim, Chang Li, Hongjie Wang, et al.
Science Advances|September 18, 2018
The adjuvant GLA-AF enhances human intradermal vaccine responsesDarrick Carter, Neal van Hoeven, Susan Baldwin, et al.
The Journal of Infectious Diseases|January 18, 2014
Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboonsSouvik Karmakar, Weidong Zhang, Gul Ahmad, et al.
Critical Care (London, England)|December 18, 2019
Development of a biomarker mortality risk model in acute respiratory distress syndromeChristian Bime, Nancy Casanova, Radu C Oita, et al.
NPJ Vaccines|January 10, 2019
Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technologyMark T Orr, Amit P Khandhar, Emilie Seydoux, et al.
Vaccine|January 9, 2014
Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboonsSouvik Karmakar, Weidong Zhang, Gul Ahmad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Serum antibodies to lipophilin B detected in late stage breast cancer patientsDarrick Carter, Davin C Dillon, Lisa D Reynolds, et al.
Scientific Reports|August 25, 2023
Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humansFrancisco J Martinez, Micheline Guillotte-Blisnick, Christèle Huon, et al.
NPJ Vaccines|October 22, 2025
Vaccination against Onchocerca volvulus induces IgG-mediated protective immunity dependent on neutrophils and complementNathan M Ryan, Jessica A Hess, Mohini Nakhale, et al.
Plos One|February 8, 2011
Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvantRhea N Coler, Sylvie Bertholet, Magdalini Moutaftsi, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Scientific Reports|May 13, 2022
Translational development of a tumor junction opening technologyJiho Kim, Chang Li, Hongjie Wang, et al.
Science Advances|September 18, 2018
The adjuvant GLA-AF enhances human intradermal vaccine responsesDarrick Carter, Neal van Hoeven, Susan Baldwin, et al.
The Journal of Infectious Diseases|January 18, 2014
Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboonsSouvik Karmakar, Weidong Zhang, Gul Ahmad, et al.
Critical Care (London, England)|December 18, 2019
Development of a biomarker mortality risk model in acute respiratory distress syndromeChristian Bime, Nancy Casanova, Radu C Oita, et al.
NPJ Vaccines|January 10, 2019
Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technologyMark T Orr, Amit P Khandhar, Emilie Seydoux, et al.
Vaccine|January 9, 2014
Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboonsSouvik Karmakar, Weidong Zhang, Gul Ahmad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Serum antibodies to lipophilin B detected in late stage breast cancer patientsDarrick Carter, Davin C Dillon, Lisa D Reynolds, et al.
Scientific Reports|August 25, 2023
Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humansFrancisco J Martinez, Micheline Guillotte-Blisnick, Christèle Huon, et al.
NPJ Vaccines|October 22, 2025
Vaccination against Onchocerca volvulus induces IgG-mediated protective immunity dependent on neutrophils and complementNathan M Ryan, Jessica A Hess, Mohini Nakhale, et al.
Plos One|February 8, 2011
Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvantRhea N Coler, Sylvie Bertholet, Magdalini Moutaftsi, et al.
Pageof 11